SCHEMBL565079

SCHEMBL565079

Nc1ccc(Nc2ccc(N)c(O)c2)cc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 5/20 0.54
CYP3A4 P08684 4/20 0.54
HSD17B10 Q99714 4/20 0.54
ALDH1A1 P00352 4/20 0.53
TDP1 Q9NUW8 3/20 0.53
THRB P10828 1/20 0.53
RECQL P46063 1/20 0.53
HIF1A Q16665 1/20 0.53
KDM4E B2RXH2 5/20 0.48
MEN1 O00255 5/20 0.48
GAA P10253 5/20 0.48
KMT2A Q03164 5/20 0.48
MAPT P10636 4/20 0.48
RAB9A P51151 2/20 0.48
POLB P06746 1/20 0.48
TSHR P16473 2/20 0.40
HDAC3 O15379 1/20 0.39
IDO1 P14902 1/20 0.39
EP300 Q09472 1/20 0.39
KAT2B Q92831 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL563875 0.91 CYP3A4 (0.67) ALOX15CYP3A4HSD17B10ALDH1A1TDP1
SCHEMBL564670 0.91 CYP3A4 (0.52) ALOX15CYP3A4HSD17B10ALDH1A1TDP1
SCHEMBL564600 0.89 ALDH1A1 (0.54) ALOX15CYP3A4HSD17B10ALDH1A1TDP1
SCHEMBL564726 0.86 CYP3A4 (0.60) ALOX15CYP3A4HSD17B10ALDH1A1TDP1
SCHEMBL565035 0.86 MAPT (0.60) ALOX15CYP3A4HSD17B10ALDH1A1TDP1
SCHEMBL477516 0.86 ALDH1A1 (0.59) ALOX15CYP3A4HSD17B10ALDH1A1TDP1
SCHEMBL28728770 0.83 ALOX15 (0.52) ALOX15CYP3A4HSD17B10ALDH1A1TDP1
SCHEMBL17506803 0.82 ALOX15 (0.47) ALOX15CYP3A4HSD17B10ALDH1A1TDP1
SCHEMBL17506810 0.82 MAPT (0.44) ALOX15CYP3A4HSD17B10ALDH1A1TDP1
SCHEMBL24660350 0.82 ALOX15 (0.40) ALOX15CYP3A4HSD17B10ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674029-B2 Method of preparing stabilized polymeric systems using polymeric peroxides Sunocs LLC (US) 2014-03-18 US disclosed
US-20120035307-A1 PROCESS FOR MAKING STABLIZED POLYMERIC SYSTEMS WITH NANOSTRUCTURES SONG CHENGQIAN (US) 2012-02-09 US disclosed
US-20120035315-A1 METHOD OF PREPARING STABLIZED POLYMERIC SYSTEMS USING POLYMERIC PEROXIDES SONG CHENGQIAN (US) 2012-02-09 US disclosed
US-7498467-B2 Antioxidant and bisaminophenol derivative IDEMITSU KOSAN CO., LTD. (JP) 2009-03-03 US disclosed
US-20080161608-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE IDEMITSU KOSAN CO., LTD. (JP) 2008-07-03 US disclosed
US-20060208227-A1 Antioxidant and bisaminophenol derivative IDEMITSU LOSAN CO., LTD (JP) 2006-09-21 US disclosed
EP-1612254-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE IDEMITSU KOSAN COMPANY LIMITED (JP) 2006-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161608-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE CBR1, CBR3, HMOX1 ALOX15 1352/4885CYP3A4 360/4885HSD17B10 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.